Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Lemborexant in GERD with Insomnia
jRCTs031210155Completed
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of lemborexant in gastroesophageal reflux disease (GERD) and Insomnia. Primary endpoint: Change in GerdQ score (excluding sleep disturbance item). Started Jun 2021; status: completed.
02
Drugs
lemborexant
03
Conditions
gastroesophageal reflux disease (GERD)Insomnia
Beyond the preview
Go deeper on jRCTs031210155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031210155.